Abiopharma

News list

HASTINGS PAUL J 🟢 acquired 656.0K shares (1 derivative) of Nkarta, Inc. (NKTX) at $1.93 ($1.1M) Transaction Date: Jan 06, 2026 | Filing ID: 007896

Full text

News bot Jan. 8, 2026, 10:50 p.m.
🔍 HASTINGS PAUL J (Executive)

Company: Nkarta, Inc. (NKTX)

Report Date: 2026-01-06
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 656,000
Detailed Transactions and Holdings:
- Acquired 94,000 shares of Common Stock (Direct)
  Date: 2026-01-06 | Code: A | equity_swap_involved: false | shares_owned_after: 416,069.00 | transaction_form_type: 4 | Footnotes: F1, F2
- Acquired 562,000 shares of Stock Option (right to buy) at $1.93 per share (Derivative)
  Date: 2026-01-06 | Code: A | Expires: 2036-01-05 | equity_swap_involved: false | shares_owned_after: 562,000.00 | transaction_form_type: 4 | Footnotes: F3
Footnotes:
- F1: Represents Restricted Stock Units ("RSUs") which vest in four equal annual installments beginning on January 14, 2027. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer.
- F2: Includes 2,000 shares acquired under the Issuer's 2020 Employee Stock Purchase Plan on November 30, 2025.
- F3: This option is scheduled to vest and become exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following January 14, 2026.